Victor Hermand

Title: Victor Hermand: Innovator in Biotherapeutics

Introduction

Victor Hermand is a notable inventor based in Lynnwood, WA (US). He has made significant contributions to the field of biotherapeutics, particularly in the development of fusion proteins and bispecific antibodies. His innovative work has the potential to advance medical treatments and improve patient outcomes.

Latest Patents

Victor Hermand holds a patent for "Heterodimeric Fc for making fusion proteins and bispecific antibodies." This patent encompasses variant-Fc-region fusion proteins, variant-Fc-region-antibodies, and heterodimeric-variant-Fc-region-bispecific-antibodies. The patent also includes nucleic acids encoding these proteins, host cells containing such nucleic acids, and methods of treatment utilizing these innovative biotherapeutics. His work in this area is crucial for the development of new therapeutic strategies.

Career Highlights

Victor is associated with Qilu Puget Sound Biotherapeutics Corporation, where he continues to push the boundaries of biotherapeutic research. His expertise in the field has led to the successful development of novel therapeutic agents that can significantly impact healthcare.

Collaborations

Victor collaborates with talented individuals such as Zhi Liu and Hua Liu. Their combined efforts contribute to the advancement of biotherapeutic innovations and enhance the research capabilities of their organization.

Conclusion

Victor Hermand is a pioneering inventor whose work in biotherapeutics is shaping the future of medical treatments. His contributions, particularly in the area of fusion proteins and bispecific antibodies, are paving the way for innovative therapeutic solutions.